Deal · partnership
Boehringer Ingelheim International GmbH / Zealand Pharma A/S
Announced Jun 15, 2011 · closed
Deal terms
- Parties
- Boehringer Ingelheim International GmbH · Zealand Pharma A/S
- Deal type
- partnership
- Territory
- Global
- Closing date
- Jun 15, 2011
- Upfront
- Not disclosed
- Milestones
- Up to $500 million
- Royalties
- Tiered royalties on net sales
- Equity terms
- None disclosed
- Headline value
- Up to $500 million (contingent on milestones)
Assets
View all →Sources
- registryprimary record
Phase 2 NASH trial of survodutide in adults with MASH
Boehringer Ingelheim International GmbH · ClinicalTrials.gov · Nov 3, 2022 · NCT05649174